News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks Michael O'Riordan March 08, 2019
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Daily News All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout Caitlin E. Cox June 19, 2018
News Conference News ACC 2018 Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018
News Daily News Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests Michael O'Riordan October 20, 2017